Literature DB >> 18264717

Interplay between human cytomegalovirus and dendritic cells in T cell activation.

Hélène Martin1, Marie Mandron, Christian Davrinche.   

Abstract

Control of human cytomegalovirus (HCMV) infection and prevention of associated diseases in immunocompetent hosts are ensured mainly by CD8+ T cells, in spite of numerous viral tricks to impair antigen presentation and activation of T cells. At sites of primary infection, dendritic cells (DCs) are in the forefront to ensure capture of viral antigens and their capacity to bypass the effects of viral immunoevasins is crucial in moulding CD8+ T cell repertoire. In HCMV-seropositive donors, the spectrum of CD8+ T cells specificities was shown to include immediate-early (IE), early (E) and late (L) gene products, a surprising finding if we consider that expression of immunoevasins could paralyse infected DCs from the IE phase of infection. In the present report, we suggest that uninfected dendritic cells could acquire HCMV-antigens derived from input virus or neosynthesis, either in soluble forms or in association with infected dead cells resulting from death-ligand-mediated apoptosis and necrosis. Activation of naïve CD8+ T cells could then occur in lymph nodes through cross-presentation by antigen-loaded DCs, providing an explanation for shape and size of the memory compartment.

Entities:  

Mesh:

Year:  2008        PMID: 18264717     DOI: 10.1007/s00430-008-0079-0

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  30 in total

1.  A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.

Authors:  V S Goldmacher; L M Bartle; A Skaletskaya; C A Dionne; N L Kedersha; C A Vater; J W Han; R J Lutz; S Watanabe; E D Cahir McFarland; E D Kieff; E S Mocarski; T Chittenden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 2.  Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance.

Authors:  Matthias J Reddehase
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

3.  Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells.

Authors:  Géraldine Arrode; Claire Boccaccio; Jean-Pierre Abastado; Christian Davrinche
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro.

Authors:  H I Cho; H Han; C C Kim; T G Kim
Journal:  J Immunother       Date:  2001 May-Jun       Impact factor: 4.456

5.  Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.

Authors:  Laura Gibson; Giampiero Piccinini; Daniele Lilleri; Maria Grazia Revello; Zhongde Wang; Susan Markel; Don J Diamond; Katherine Luzuriaga
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

6.  Antigen crosspresentation by human plasmacytoid dendritic cells.

Authors:  Guillaume Hoeffel; Anne-Claire Ripoche; Diana Matheoud; Michelina Nascimbeni; Nicolas Escriou; Pierre Lebon; Farhad Heshmati; Jean-Gérard Guillet; Monique Gannagé; Sophie Caillat-Zucman; Nicoletta Casartelli; Olivier Schwartz; Henri De la Salle; Daniel Hanau; Anne Hosmalin; Concepción Marañón
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

7.  Dendritic cell-induced apoptosis of human cytomegalovirus-infected fibroblasts promotes cross-presentation of pp65 to CD8+ T cells.

Authors:  Marie Mandron; Hélène Martin; Béatrice Bonjean; Jacqueline Lulé; Eric Tartour; Christian Davrinche
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

8.  Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells.

Authors:  Torsten Bunde; Alexander Kirchner; Bodo Hoffmeister; Dirk Habedank; Roland Hetzer; Georgy Cherepnev; Susanna Proesch; Petra Reinke; Hans-Dieter Volk; Hans Lehmkuhl; Florian Kern
Journal:  J Exp Med       Date:  2005-03-28       Impact factor: 14.307

9.  Mycobacteria target DC-SIGN to suppress dendritic cell function.

Authors:  Teunis B H Geijtenbeek; Sandra J Van Vliet; Estella A Koppel; Marta Sanchez-Hernandez; Christine M J E Vandenbroucke-Grauls; Ben Appelmelk; Yvette Van Kooyk
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

10.  Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination.

Authors:  Wolfgang Kastenmuller; Georg Gasteiger; Julian H Gronau; Robert Baier; Ronny Ljapoci; Dirk H Busch; Ingo Drexler
Journal:  J Exp Med       Date:  2007-08-20       Impact factor: 14.307

View more
  6 in total

Review 1.  Oncomodulation by human cytomegalovirus: evidence becomes stronger.

Authors:  Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-02-07       Impact factor: 3.402

2.  Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method.

Authors:  Henry Ogbomo; Janina Geiler; Anke Leutz; Kristina von Kietzell; Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-10-08       Impact factor: 3.402

Review 3.  T Cells and Regulated Cell Death: Kill or Be Killed.

Authors:  Johan Spetz; Adam G Presser; Kristopher A Sarosiek
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-29       Impact factor: 6.813

4.  Immunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newborn.

Authors:  William J Muller; Cheryl A Jones; David M Koelle
Journal:  Curr Immunol Rev       Date:  2010

Review 5.  Oncomodulation by human cytomegalovirus: novel clinical findings open new roads.

Authors:  Martin Michaelis; Peter Baumgarten; Michel Mittelbronn; Pablo Hernáiz Driever; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2010-10-22       Impact factor: 3.402

6.  Epidemiology of human cytomegalovirus (HCMV) in an urban region of Germany: what has changed?

Authors:  Paul R Lübeck; Hans Wilhelm Doerr; Holger F Rabenau
Journal:  Med Microbiol Immunol       Date:  2009-12-01       Impact factor: 3.402

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.